Tenet Healthcare Corporation

NYSE:THC Stock Report

Market Cap: US$17.0b

Tenet Healthcare Management

Management criteria checks 2/4

Tenet Healthcare's CEO is Saum Sutaria, appointed in Sep 2021, has a tenure of 4.83 years. total yearly compensation is $24.66M, comprised of 6.1% salary and 93.9% bonuses, including company stock and options. directly owns 0.51% of the company’s shares, worth $86.14M. The average tenure of the management team and the board of directors is 4.5 years and 6.7 years respectively.

Key information

Saum Sutaria

Chief executive officer

US$24.7m

Total compensation

CEO salary percentage6.08%
CEO tenure4yrs
CEO ownership0.5%
Management average tenure4.5yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

Tenet Healthcare Continues To Win In Q2, But Medicaid Cuts May Threaten Growth Beyond 2026

Jul 23

These 4 Measures Indicate That Tenet Healthcare (NYSE:THC) Is Using Debt Extensively

Jul 04
These 4 Measures Indicate That Tenet Healthcare (NYSE:THC) Is Using Debt Extensively

Shareholders May Be More Conservative With Tenet Healthcare Corporation's (NYSE:THC) CEO Compensation For Now

May 16
Shareholders May Be More Conservative With Tenet Healthcare Corporation's (NYSE:THC) CEO Compensation For Now

There's No Escaping Tenet Healthcare Corporation's (NYSE:THC) Muted Earnings Despite A 26% Share Price Rise

May 07
There's No Escaping Tenet Healthcare Corporation's (NYSE:THC) Muted Earnings Despite A 26% Share Price Rise

Is Now An Opportune Moment To Examine Tenet Healthcare Corporation (NYSE:THC)?

Apr 29
Is Now An Opportune Moment To Examine Tenet Healthcare Corporation (NYSE:THC)?

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Apr 02
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Minimal Medicaid Exposure Puts Tenet Healthcare In A Good Position

Mar 20

The Market Doesn't Like What It Sees From Tenet Healthcare Corporation's (NYSE:THC) Earnings Yet

Mar 15
The Market Doesn't Like What It Sees From Tenet Healthcare Corporation's (NYSE:THC) Earnings Yet

Solid Earnings May Not Tell The Whole Story For Tenet Healthcare (NYSE:THC)

Feb 25
Solid Earnings May Not Tell The Whole Story For Tenet Healthcare (NYSE:THC)

The Tenet Healthcare Corporation (NYSE:THC) Full-Year Results Are Out And Analysts Have Published New Forecasts

Feb 21
The Tenet Healthcare Corporation (NYSE:THC) Full-Year Results Are Out And Analysts Have Published New Forecasts

Here's Why Tenet Healthcare (NYSE:THC) Has Caught The Eye Of Investors

Jan 29
Here's Why Tenet Healthcare (NYSE:THC) Has Caught The Eye Of Investors

Tenet Healthcare Stock: An Improved Option Here (Rating Upgrade)

Dec 30

Tenet Healthcare: Walk-In Surgical Care Facilities Are A Key Revenue Driver

Dec 17

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Nov 17
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

Nov 04

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Oct 30
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare: Becoming A Very Healthy Business

Sep 09

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Aug 29
User avatar

Expansive Growth Strategy And Cybersecurity Concerns Cast A Shadow On Financial Health

Aggressive expansion and significant investments may strain operational efficiencies and financial resources, potentially impacting future earnings and liquidity.

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

Tenet Healthcare: Shrinking To Grow

Feb 04

CEO Compensation Analysis

How has Saum Sutaria's remuneration changed compared to Tenet Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

US$1b

Mar 31 2025n/an/a

US$1b

Dec 31 2024US$25mUS$2m

US$3b

Sep 30 2024n/an/a

US$3b

Jun 30 2024n/an/a

US$3b

Mar 31 2024n/an/a

US$3b

Dec 31 2023US$19mUS$2m

US$611m

Sep 30 2023n/an/a

US$469m

Jun 30 2023n/an/a

US$499m

Mar 31 2023n/an/a

US$414m

Dec 31 2022US$11mUS$1m

US$411m

Sep 30 2022n/an/a

US$558m

Jun 30 2022n/an/a

US$875m

Mar 31 2022n/an/a

US$957m

Dec 31 2021US$21mUS$1m

US$915m

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$434m

Mar 31 2021n/an/a

US$402m

Dec 31 2020US$9mUS$1m

US$399m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$112m

Dec 31 2019US$14mUS$962k

-US$226m

Compensation vs Market: Saum's total compensation ($USD24.66M) is above average for companies of similar size in the US market ($USD13.62M).

Compensation vs Earnings: Saum's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Saum Sutaria (52 yo)

4yrs
Tenure
US$24,661,553
Compensation

Dr. Saumya Sutaria, also known as Saum, M.D., serves as Member of Advisory Board at Vida Health, Inc. Dr. Sutaria served as Chief Operating Officer at Tenet Healthcare Corp. since January 06, 2019 until Se...


Leadership Team

NamePositionTenureCompensationOwnership
Saumya Sutaria
Chairman & CEO4yrsUS$24.66m0.51%
$ 86.1m
Sun Park
Executive VP & CFO1.7yrsUS$4.70m0.017%
$ 2.8m
Lisa Foo
Executive VP & Chief Operating Officerless than a yearUS$5.16m0.024%
$ 4.0m
Paola Arbour
Executive VP & Chief Information Officer7.3yrsUS$3.38m0.023%
$ 3.9m
Thomas Arnst
EVP, Chief Administrative Officer4.5yrsUS$5.82m0%
$ 0
William McDowell
Vice President of Investor Relationsno datano datano data
Jana Durfee
Senior VP & Chief Compliance Officerno datano datano data
Michael Maloney
Executive Vice President of Corporate Development8.6yrsno datano data
Clint Hailey
Chief Managed Care Officer & Senior VP18.2yrsno datano data
Liz Johnson
Chief Applied Clinical Informatics Officerno datano datano data
Michele Finney
Chief Executive Officer of Desert Market8.6yrsno datano data
Brett Brodnax
Executive Chairman of USPIless than a yearno datano data
4.5yrs
Average Tenure
60yo
Average Age

Experienced Management: THC's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Saumya Sutaria
Chairman & CEO4.8yrsUS$24.66m0.51%
$ 86.1m
James Bierman
Independent Director7.9yrsUS$346.05k0.031%
$ 5.2m
Stephen Rusckowski
Independent Director2.3yrsUS$334.62k0.0059%
$ 1.0m
Meghan FitzGerald
Independent Director7.3yrsUS$350.05k0.012%
$ 2.1m
Joseph Kerrey
Lead Independent Director24.5yrsUS$546.59k0.020%
$ 3.4m
Richard Mark
Independent Director7.8yrsUS$344.55k0.024%
$ 4.1m
Richard Fisher
Independent Director7.8yrsUS$360.05k0.0086%
$ 1.5m
Tammy Romo
Independent Director10.5yrsUS$365.55k0.061%
$ 10.3m
Christopher Lynch
Independent Director6.1yrsUS$340.55k0.0064%
$ 1.1m
Cecil Haney
Independent Director4.7yrsUS$336.55k0.015%
$ 2.5m
Nadja West
Independent Director5.9yrsUS$332.55k0.031%
$ 5.2m
Roy Blunt
Independent Director2.1yrsUS$340.55k0.0049%
$ 836.9k
6.7yrs
Average Tenure
68.5yo
Average Age

Experienced Board: THC's board of directors are considered experienced (6.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/05 17:17
End of Day Share Price 2025/09/05 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tenet Healthcare Corporation is covered by 48 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverAvondale Partners
Hua HaBaird
Ishan MajumdarBaptista Research